MBX-4132

• CAT Number: I020018
• CAS Number: 2286411-30-9
• Molecular Formula: C₁₈H₁₅FN₄O₂
• Molecular Weight: 338.34
• Purity: ≥95%
• Target: Bacterial
• IUPAC Name: N-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-3,4-dihydro-1H-isoquinoline-2-carboxamide
• InChI: InChI=1S/C18H15FN4O2/c19-15-7-5-13(6-8-15)16-21-22-17(25-16)20-18(24)23-10-9-12-3-1-2-4-14(12)11-23/h1-8H,9-11H2,(H,20,22,24)
• InChIKey: OZHWSOOZCIJFQN-UHFFFAOYSA-N
• SMILES: C1CN(CC2=CC=CC=C21)C(=O)NC3=NN=C(O3)C4=CC=C(C=C4)F

MBX-4132（Cat No.:I020018）is an innovative antibiotic under investigation for its potential to combat multidrug-resistant bacterial infections, particularly those caused by Gram-negative pathogens. It operates through a novel mechanism distinct from traditional antibiotics, which allows it to evade common resistance pathways. MBX-4132 shows efficacy in targeting bacterial ribosomes, thereby inhibiting protein synthesis and ultimately leading to bacterial cell death. With promising preclinical results, MBX-4132 holds potential in addressing the critical need for new treatments against resistant infections, particularly for hospital-acquired infections and difficult-to-treat bacterial strains.

Reference

[1]. Anette Breindl, et al. Ribosome allows for multiple shots on giant goal.